KALA
Closed
Kala Pharmaceuticals Inc
4.84
+0.08 (+1.68%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 4.76
Day's Range: 4.51 - 5.18
Send
sign up or login to leave a comment!
When Written:
13.8
Kala Pharmaceuticals Inc is a biopharmaceutical company that focuses on the development and commercialization of innovative treatments for various eye diseases. The company was founded in 2009 and is headquartered in Watertown, Massachusetts.
Kala Pharmaceuticals' lead product, INVELTYS, is an ophthalmic solution used to treat inflammation and pain following ocular surgery. The company is also developing other products for the treatment of dry eye disease, allergic conjunctivitis, and other ocular conditions.
Kala Pharmaceuticals has partnerships with various pharmaceutical companies, including Bausch Health, Sun Pharma, and Paragon BioTeck, to develop and commercialize its products. The company is publicly traded on the NASDAQ stock exchange under the ticker symbol KALA.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Kala Pharmaceuticals' lead product, INVELTYS, is an ophthalmic solution used to treat inflammation and pain following ocular surgery. The company is also developing other products for the treatment of dry eye disease, allergic conjunctivitis, and other ocular conditions.
Kala Pharmaceuticals has partnerships with various pharmaceutical companies, including Bausch Health, Sun Pharma, and Paragon BioTeck, to develop and commercialize its products. The company is publicly traded on the NASDAQ stock exchange under the ticker symbol KALA.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








